UBS Raises Price Target on Procter & Gamble (PG) Following 3c EPS Beat
UBS reiterated a Neutral rating on Procter & Gamble (NYSE: PG), and raised the price target to $81.00 (from $78.00), following the company's 1Q16 earnings report. PG outperformed FYQ1 EPS expectations, delivering $0.98 vs. consensus of $0.95. Looking forward, PG maintained FY16 EPS guidance.
Analyst Stephen Powers commented, "Overall, PG outperformed FYQ1 EPS expectations, delivering $0.98 (vs. UBSe/cons. of $0.95), as productivity, commodities, and FX transaction benefits offset another quarter of top-line pressure (SG&A was 27.9% of sales vs. UBSe at 29.5%). Organic growth fell -1% (vs. UBSe of -0.2%) due to competition, SKU cuts (largely in EM), inventory destocking, and capacity constraints, but matched depressed pre-quarter whispers."
For an analyst ratings summary and ratings history on Procter & Gamble click here. For more ratings news on Procter & Gamble click here.
Shares of Procter & Gamble closed at $77.03 yesterday.